Charmaine Roson - Philippines

“If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines Releases New Guidance on Class A Medical Devices

Published on: August 24th, 2021

FDA Releases List of 1,242 Medical Device Categories That Require a CMDN

To further help with clarifying the regulatory requirements for medical device manufacturers seeking market access in the Philippines, the FDA has released a list of Class A 1,242 product categories in Circular 2021-017 on August 16, 2021. Medical device manufacturers of Class A products specified in Annex A or under the ASEAN MDD, must obtain a Certificate of Medical Device Notification (CMDN). This must be done before manufacturing, distributing, importing, selling, and/or advertising the medical device. If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period. Classification of a medical device is subject to change if features of a product, such as intended use or duration of use, were to change.

This guidance will take effect fifteen (15) days after its publication in a newspaper of general circulation and when three (3) certified copies are filed to the UP Law Center.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests for the Philippines.

Blog Posts

Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
Read more
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).
Read more
Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more